Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Aratana Therapeutics (Kansas City, KS) a clinical-stage animal health company focused on pain, cancer, inflammation, cachexia and frailty, closed a $15.5M Series B financing. Participants include Ewing Marion Kauffman Foundation, MPM Capital, Cultivian Ventures and Avalon Ventures.

Putney (Portland, ME) a commercial-stage pharmaceutical company focused on bioequivalents and specialty drugs for the veterinary market, closed a $21M Series C financing. Participants include NewSpring Health Capital and Safeguard Scientifics.

Aratana Therapeutics (Kansas City, KS) a clinical-stage animal health company focused on pain, cancer, inflammation, cachexia and frailty, closed a $20M Series A financing. Participants include MPM Capital, Cultivian Ventures and Avalon Ventures.

Juvaris BioTherapeutics (Pleasanton, CA) a clinical-stage biopharma company focused on adjuvanted vaccines for seasonal flu and immunotherapeutics for Leukemia and animal health, closed a $12.5M Series B financing. Participants include SV Life Sciences and Kleiner Perkins Caufield & Byers. *Estimated first close of round

Piedmont Pharmaceuticals (Greensboro, NC) a commercial-stage specialty pharma company focused on parasitology and drug delivery systems for human and companion animal use, closed a $5M Series C financing. Participants include CM Capital.

Okapi Sciences (Belgium) early-stage developer of antiviral drugs for veterinary applications, closed a $10.8M Series A financing. Participants include Agri Investment Fund, Dutch Thuja Capital, Fortis Private Equity Arkimedes, KBC Arkiv, Vinnof, Gemma Frisius Fund, K.U.Leuven and Spinventure.

  

to top of page...